From: Clinical relevance of aortic calcification in urolithiasis patients
 | Volunteers | Non-stone group | P value |
---|---|---|---|
n | 296 | 148 | Â |
Age (years)a | 64 (56–72) | 62 (54–72) | 0.333 |
Gender (Male)a, n= | 176 (59%) | 89 (60%) | 0.919 |
Body mass indexa (kg/m2) | 24 ± 4 | 24 ± 4 | 0.849 |
Comorbidities | Â | Â | Â |
Hypertensiona, n= | 85 (29%) | 43 (29%) | 1.000 |
Diabetesa, n= | 47 (16%) | 31 (21%) | 0.189 |
Cardiovascular diseasea, n= | 42 (14%) | 20 (14%) | 0.886 |
eGFR (mL/min/1.73 m2) | 76 (66–85) | 72 (61–87) | 0.127 |
Stage 3B CKD, n= | 12 (4%) | 6 (4%) | 1.000 |
Uric acid > 7.0 mg/dL, n= | 34 (11%) | 24 (16%) | 0.180 |
Dyslipidemia (Total cholesterol >220, or Triglyceride >140Â mg/dL), n= | 21 (7%) | 15 (10%) | 0.401 |
Urine protein > 30 mg/dL, n= | N/A | 22 (15%) |  |
Aortic calcification index (ACI) | N/A | 6.7 (0.8-19.2) | Â |